Clopidogrel

Preview FDA label, AvPAK, oral, effective 2026-01-14. Full label on DailyMed

Quoted from the FDA label. Product labels differ by manufacturer and change over time; confirm against the label for the product you are using. Not yet reviewed by a ClinDose pharmacist.

Dosing in kidney impairment

Renal Impairment Experience is limited in patients with severe and moderate renal impairment [see Clinical Pharmacology ] .

Dosing in liver impairment

Hepatic Impairment No dosage adjustment is necessary in patients with hepatic impairment [see Clinical Pharmacology ] .